Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Not Confirmed
Not Confirmed
08-10 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Not Confirmed
08-10 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
04 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halia-therapeutics-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference-302546054.html
16 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halia-therapeutics-completes-first-in-human-phase-1-study-of-ht-4253-a-novel-lrrk2-inhibitor-targeting-neuroinflammation-302482102.html
11 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halia-therapeutics-awarded-novo-nordisk-golden-ticket-to-advance-obesity-and-inflammation-research-302396740.html
06 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halia-therapeutics-strengthens-leadership-and-clinical-operations-team-302342474.html
11 Dec 2024
// PRESS RELEASE
https://haliatx.com/halia-therapeutics-announces-positive-topline-data-and-advances-to-second-stage-of-phase-2-clinical-trial-for-ht-6184-in-patients-with-low-risk-myelodysplastic-syndromes-lr-mds/
10 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halia-therapeutics-announces-positive-topline-data-and-advances-to-second-stage-of-phase-2-clinical-trial-for-ht-6184-in-patients-with-low-risk-myelodysplastic-syndromes-lr-mds-302325033.html
ABOUT THIS PAGE